Q4 2025 Holdings
Filed 2026-02-17 | 55 holdings | $705.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $118.7M | 682,212 | 16.8% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $81.0M | 600,747 | 11.5% |
| Insmed Inc(INSM)Put | COM PAR $.01 | 457669307 | $73.1M | 420,000 | 10.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $54.4M | 64,699 | 7.7% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $54.3M | 50,500 | 7.7% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $25.3M | 719,365 | 3.6% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $25.2M | 2,013,602 | 3.6% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $24.7M | 533,698 | 3.5% |
| Proshares TR II(UGL) | ULTRA GOLD | 74347W601 | $24.5M | 442,119 | 3.5% |
| Uniqure NV(QURE) | SHS | N90064101 | $24.5M | 1,023,539 | 3.5% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $17.7M | 503,936 | 2.5% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $17.5M | 190,752 | 2.5% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $15.6M | 70,824 | 2.2% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $14.0M | 767,098 | 2.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $11.4M | 144,376 | 1.6% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $8.5M | 205,090 | 1.2% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $8.3M | 104,190 | 1.2% |
| Quest Diagnostics Inc(DGX) | COM | 74834L100 | $7.1M | 40,817 | 1.0% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $6.9M | 17,400 | 1.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $6.3M | 695,982 | 0.9% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $6.2M | 59,200 | 0.9% |
| Proshares TR II(UGL)Put | ULTRA GOLD | 74347W601 | $5.6M | 100,000 | 0.8% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $5.0M | 137,800 | 0.7% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $4.9M | 119,741 | 0.7% |
| Palisade BIO Inc(PALI) | COM | 696389402 | $4.7M | 1,992,367 | 0.7% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $4.3M | 60,100 | 0.6% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $4.2M | 96,285 | 0.6% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $4.2M | 138,508 | 0.6% |
| Prokidney Corp(PROK) | SHS CL A | 74291D104 | $4.1M | 1,838,411 | 0.6% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $3.8M | 17,740 | 0.5% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $3.3M | 14,500 | 0.5% |
| Belite BIO Inc(BLTE) | SPONSORED ADS | 07782B104 | $2.9M | 17,989 | 0.4% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $2.8M | 129,800 | 0.4% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $2.7M | 70,700 | 0.4% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $2.6M | 33,407 | 0.4% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $2.4M | 5,000 | 0.3% |
| Soleno Therapeutics Inc(SLNO)Call | COM | 834203309 | $2.3M | 50,000 | 0.3% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $2.0M | 22,951 | 0.3% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $1.9M | 68,653 | 0.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $1.8M | 40,000 | 0.3% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $1.7M | 141,061 | 0.2% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $1.6M | 20,400 | 0.2% |
| Brightspring Health Svcs Inc(BTSG) | COM | 10950A106 | $1.6M | 41,600 | 0.2% |
| Pepgen Inc(PEPG) | COM | 713317105 | $1.3M | 205,324 | 0.2% |
| Abivax SA(ABVX)Call | SPONSORED ADS | 00370M103 | $1.3M | 9,900 | 0.2% |
| Celcuity Inc(CELC) | COM | 15102K100 | $1.3M | 12,900 | 0.2% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $1.2M | 29,200 | 0.2% |
| Ocular Therapeutix Inc(OCUL)Call | COM | 67576A100 | $1.0M | 85,200 | 0.1% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $814.8K | 8,100 | 0.1% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $754.9K | 41,570 | 0.1% |